AusPol MMRV vaccine legislature could cause Cancer | TGA Sponsored by GlaxoSmithKline

img courtesy of Australian Regulatory Guidelines for  Biologicals  Part 3 -  Access to unapproved biologicals Version 1.0, June 2011

img courtesy of Australian Regulatory Guidelines for Biologicals Part 3 – Access to unapproved biologicals Version 1.0, June 2011

How about testing for carcinogenicity or mutagenicity prior to administering/ legislating Vaccines? No need to test for cancer causing components prior to injecting babies or infants? What about testing for any effect on fertility?  Nope, not needed. 

TGA says approved while supporting legislature mandates potentially non-effective and unproven MMRII (Merck & Co.) & Priorix-Tetra (GlaxoSmithKline- GSK); with the latter not tested for Carcinogenicity or Mutagenicity- see below excerpt from priorix_tetra_pi_008_approved

The use of PRIORIX-TETRA in asymptomatic HIV subjects has not been studied.

Administration of PRIORIX-TETRA may be considered with caution in this population when, in the opinion of the physician, withholding the vaccine entails a greater risk.
No clinical data are available on the safety, immunogenicity, and efficacy of PRIORIX-TETRA in adolescents and adults.
Carcinogenicity and Mutagenicity
PRIORIX-TETRA has not been evaluated for carcinogenicity or mutagenicity.
Impairment of Fertility
PRIORIX-TETRA has not been evaluated for its potential to impair fertility.”

The current “Good Manufacturing Practices” vetting currently employed by the TGA only covers the process in manufacture and not any testing regimen requirements/ proven data sets on the Vaccines or “biologicals” themselves.This needs to change!

It is clearly evident, whilst considering the above statement from GSK’s Priorix-Tetra Product Description, that the Australian Government only superficially vets their “Sponsor“; forcing thousands of Parents to “immunise” their children and potentially endangering thousands of Babies by possibly exposing them to Carcinogens and/or further affecting their levels of fertility later on in life.

Perhaps it is time for some “Good Government Practices” and a complete revamp of the current approvals “Sponsorship-based” program as stated in the below link.

Read on at Source: Biological standards | Therapeutic Goods Administration (TGA)

Advertisements